Quest Diagnostics (DGX) Given a $98.00 Price Target by Jefferies Group Analysts

Olive Hawkins
December 7, 2017

Parallel Advisors LLC now owns 1,291 shares of the medical research company's stock worth $140,000 after purchasing an additional 12 shares during the last quarter. Also, Chairman Stephen H. Rusckowski sold 59,235 shares of the company's stock in a transaction that occurred on Tuesday, September 12th. Oppenheimer Asset Management Inc sold 7,033 shares as Quest Diagnostics Inc (DGX)'s stock rose 10.72%. The stock increased 0.53% or $0.18 during the last trading session, reaching $34.25. About 1.27 million shares traded. It has underperformed by 8.78% the S&P500. Advantage Incorporated invested in 29,782 shares or 2.81% of the stock. Macquarie Group Ltd sold 1.08 million shares as the company's stock rose 10.72% with the market.

Macquarie Group Ltd, which manages about $54.70B US Long portfolio, upped its stake in Cable One Inc by 6,667 shares to 72,026 shares, valued at $51.20M in 2017Q2, according to the filing. About 345,398 shares traded. It has outperformed by 22.34% the S&P500.

Analysts await Federated Investors, Inc. (NYSE:PAYC) to report earnings on February, 14. Flowserve Corporation earnings have declined with an annualized rate of -16.9% over the last 5 years. DGX's profit will be $190.82 million for 17.44 P/E if the $1.40 EPS becomes a reality. After $1.32 actual earnings per share reported by General Motors Company for the previous quarter, Wall Street now forecasts -0.76% negative EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 1 sale for $1.95 million activity. Therefore 0 are positive. Consensus earnings estimates are far from ideal, but they are watched by many investors and play an important role in measuring the appropriate valuation for a stock. FBR Capital maintained Quest Diagnostics Incorporated (NYSE:DGX) on Wednesday, April 12 with "Outperform" rating. The stock has "Sector Perform" rating by RBC Capital Markets on Friday, October 23. The firm has "Hold" rating by Argus Research given on Monday, October 30. As per Tuesday, September 8, the company rating was maintained by Chardan Capital Markets. Pub Sector Pension Board holds 0.01% or 15,483 shares. The stock has "Buy" rating by Bank of America on Tuesday, July 25. The company was maintained on Wednesday, April 26 by Mizuho. The firm has "Buy" rating by UBS given on Monday, November 14. These ratios show how well income is generated through operations, and are important to both creditors and investors.

LG announces classy V30 Signature Edition in Korea
The G6 from earlier this year felt premium in your hand, while the V30 simply one-ups things with gloss and shine everywhere. It will run the latest Android 8.0 Oreo system and be fitted with a 6-inch OLED FullVision screen.

Are Analysts Bearish Ares Management, LP (NYSE:ARES) After Last Week?
The stock of Ares Capital Corporation (NASDAQ:ARCC) earned "Hold" rating by BMO Capital Markets on Wednesday, August 23. According to Finviz reported data, The SMA20 of the stock is at -2.57%, SMA50 is -21 percent, while SMA200 is -23.75%.

Czech PM wants European Union to withdraw migrants lawsuit
They face heavy fines for failing to comply with any eventual ruling by the Luxembourg-based European Court of Justice. Thus, they may dissuade people from making donations from overseas to civil society organisations in Hungary.

Investors sentiment increased to 1.19 in Q2 2017. Its down 0.05, from 1.04 in 2017Q1. 18 funds opened positions while 40 raised stakes. Trustmark Bancshares Tru Department invested in 0.17% or 13,411 shares. Manufacturers Life Insur The owns 136,620 shares or 0% of their U.S. portfolio. Capstone Asset Mngmt owns 119,657 shares for 0.37% of their portfolio. Kingstown Capital Management L.P., a New York-based fund reported 2.00 million shares. Godshalk Welsh Cap Mngmt invested in 0.58% or 5,300 shares. Aberdeen Asset Mngmt Public Ltd Co Uk reported 204,699 shares or 0.08% of all its holdings. The stock of Quest Diagnostics Incorporated (NYSE:DGX) has "Neutral" rating given on Friday, October 21 by Mizuho. Tdam Usa holds 0.04% or 6,761 shares.

Trillium Asset Management Llc decreased Paypal Hldgs Inc stake by 14,584 shares to 539,657 valued at $28.96M in 2017Q2. 101,189 were reported by First Trust. Utah Retirement Systems reported 25,034 shares.

The Return on Invested Capital (aka ROIC) for Quest Diagnostics Incorporated (NYSE:DGX) is 0.533273. The company has an Average True Range (ATR) value of 1.82, while a Beta Value of 0.59. A 4 analysts rate it as either a buy or a strong buy, while 1 believe that investors should either steer clear of (NYSE:DGX) or, if they already own its stock, sell it. WFG Advisors LP raised its stake in Quest Diagnostics by 45.3% during the 2nd quarter. ValuEngine upgraded shares of Quest Diagnostics from a "hold" rating to a "buy" rating in a report on Friday, September 1st. American Assets has invested 0.34% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Meag Munich Ergo Kapitalanlagegesellschaft Mbh accumulated 32,989 shares. Out of 18 total analysts who were surveyed, 1 rated it a Strong Sell, 13 rated it hold, and 4 rated it a Strong Buy. Ghp Advisors owns 8,183 shares or 0.14% of their United States portfolio. Engineers Gate Manager Lp stated it has 0.07% in Quest Diagnostics Incorporated (NYSE:DGX). Dynamic Mgmt Limited invested 0.68% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). GrubHub Inc. (NYSE:GRUB) has risen 94.22% since December 5, 2016 and is uptrending.

Quest Diagnostics Incorporated (NYSE:DGX) has a market cap of $13.73 billion and over the last 12 months, DGX has risen by 13.91%. Janney Montgomery Scott Ltd Llc reported 8,726 shares. Gateway Invest Advisers Ltd Co reported 0.15% in Quest Diagnostics Incorporated (NYSE:DGX). Hollencrest Securities Limited Liability Corp, California-based fund reported 22,092 shares. Compton Cap Mgmt Incorporated Ri holds 0.24% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX) for 4,800 shares. Therefore 35% are positive. Canaccord Genuity maintained the stock with "Buy" rating in Monday, September 11 report. The firm's quarterly revenue was up 2.4% on a year-over-year basis. research analysts forecast that Quest Diagnostics Inc will post 5.65 earnings per share for the current fiscal year. However, the company's most recent quarter increase of 3.7% looks unattractive. The stock has "Hold" rating by Jefferies on Friday, November 24. Canaccord Genuity reaffirmed a "buy" rating and issued a $118.00 target price on shares of Quest Diagnostics in a report on Wednesday, September 13th. The rating was maintained by Jefferies on Thursday, October 19 with "Hold". Acrospire Investment Management LLC now owns 1,600 shares of the medical research company's stock valued at $178,000 after purchasing an additional 1,200 shares during the last quarter.

Other reports by

Discuss This Article